TIBER CREEK GROUP OBO ABBVIE INC.

Lobbying client · District of Columbia · filed 2026 to 2026

Government Relations. / Biopharmaceutical company.

$20,000 Reported spend

2 Filings counted

1 Outside firm hired

1 Bill named

Spend is reported income plus in-house expenses across 2 filings. Everything on this page comes from one LDA client record (75626), filed by the registrant listed below.

Who filed for this client 1

B HALL STRATEGIES, LLC $20,000 Outside firm · 2 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

Bills named in these filings 1

H.R. 4299
Protecting Patient Access to Cancer and Complex Therapies Act

1 filing

Reported by year 1 year

2026 $20,000 2 filings

Issues lobbied 1

Medicare/Medicaid 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 1

SENATE 1

Recent filings 2 total

Q3 report

B HALL STRATEGIES, LLC

3rd Quarter 2026 (July 1 - Sep 30) · Senate · $20,000 income · posted Oct 20, 2026

View → Registration

B HALL STRATEGIES, LLC

3rd Quarter 2026 (July 1 - Sep 30) · posted Oct 20, 2026

View →

Affiliated organisations 1

ABBVIE INC. United States of America named on 1 filing

Section 6 of the LD-2: organisations that contribute to or take part in this client's lobbying.

Keep going

Filings through October 20, 2026, the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.